Feb 172011
Daily inhaled corticosteroids (ICS) may retard growth in children, who would rather play than take daily inhalers. Martinez et al randomized children with mild persistent asthma to four groups, one of which was beclomethasone + albuterol as rescue therapy only (i.e., no daily ICS), for 44 months. They did slightly worse than children taking daily ICS (35% exacerbation rate vs ~30%, and 8.5% treatment failure rate vs 3 – 6%), but grew 1 cm taller over the study period, with no adverse events. (n=843). Lancet 2011;377:650-657.
You may also like -
FDA approves Breo Ellipta, a new once-daily COPD inhaler treatmentFDA approves Breo Elipta, a new once-daily COPD inhaler treatment
Long-acting beta agonist safety for asthma (Review, Thorax)
Lansoprazole didn't help kids with uncontrolled asthma (RCT, JAMA)
Exhaled nitric oxide's clinical applications: ATS Practice Guideline (AJRCCM)Liked this post? Get a weekly email update (no spam, ever), and explore our library of pulmonary and critical care guidelines, practice updates and review articles.